DNAJB14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.647600E-01
Normal-vs-Stage2
6.485400E-01
Normal-vs-Stage3
1.971760E-01
Normal-vs-Stage4
5.900200E-01
Stage1-vs-Stage2
6.908200E-01
Stage1-vs-Stage3
6.825900E-02
Stage1-vs-Stage4
3.401600E-01
Stage2-vs-Stage3
2.379600E-01
Stage2-vs-Stage4
7.716100E-02
Stage3-vs-Stage4
1.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.272800E-01
Normal-vs-AfricanAmerican
8.426000E-01
Normal-vs-Asian
3.251600E-01
Caucasian-vs-AfricanAmerican
2.719200E-01
Caucasian-vs-Asian
3.286200E-01
AfricanAmerican-vs-Asian
1.490610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.377400E-01
Normal-vs-Female
7.380600E-01
Male-vs-Female
6.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.659000E-01
Normal-vs-Age(41-60Yrs)
9.035600E-01
Normal-vs-Age(61-80Yrs)
4.716600E-01
Normal-vs-Age(81-100Yrs)
3.220800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.495400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.330000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.522800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.226150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.714100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.908600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.554200E-01
Normal-vs-Daily Drinker
1.869040E-01
Normal-vs-Weekly Drinker
5.344800E-01
Normal-vs-Occasional Drinker
9.904800E-01
Normal-vs-Social Drinker
9.398200E-01
Non Drinker-vs-Daily Drinker
2.673400E-01
Non Drinker-vs-Weekly Drinker
9.442400E-01
Non Drinker-vs-Occasional Drinker
1.589040E-01
Non Drinker-vs-Social Drinker
3.382200E-01
Daily Drinker-vs-Weekly Drinker
3.950600E-01
Daily Drinker-vs-Occasional Drinker
3.214000E-02
Daily Drinker-vs-Social Drinker
1.320190E-01
Weekly Drinker-vs-Occasional Drinker
2.875800E-01
Weekly Drinker-vs-Social Drinker
4.401800E-01
Occasional Drinker-vs-Social Drinker
8.685400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.089370E-01
Normal-vs-Grade 2
1.742140E-02
Normal-vs-Grade 3
2.563500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.207800E-01
Grade 1-vs-Grade 3
2.374200E-01
Grade 1-vs-Grade 4
1.089370E-01
Grade 2-vs-Grade 3
2.654800E-01
Grade 2-vs-Grade 4
1.742140E-02
Grade 3-vs-Grade 4
2.563500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.682400E-01
Normal-vs-NonDiabetic
5.780400E-01
Diabetic-vs-NonDiabetic
5.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.034200E-01
Normal-vs-NoPancreatitis
6.144400E-01
Pancreatitis-vs-NoPancreatitis
1.690830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.858400E-01
Normal-vs-N1
6.615000E-01
N0-vs-N1
7.411400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.833400E-01
Normal-vs-TP53-NonMutant
8.391800E-01
TP53-Mutant-vs-TP53-NonMutant
5.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
